Navigation Links
InterMune Announces Progress on Pirfenidone in IPF
Date:4/21/2008

- Initiating planned roll-over study for CAPACITY patients in Q3 -

- Patient retention and conduct of Phase 3 CAPACITY program remain

excellent to date - - Abstract of Shionogi Phase 3 pirfenidone study now available on ATS

website -

BRISBANE, Calif., April 21 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that it will initiate an open-label roll-over study to evaluate the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF). The roll-over study will be open to patients who complete one of the two concurrent Phase 3 CAPACITY studies of pirfenidone in IPF. InterMune expects that the first patient will enter the roll-over study in August 2008. Additional information regarding the design and objectives of the pirfenidone roll-over study will be available at http://www.clinicaltrials.gov within approximately one week. The anticipated 2008 costs of conducting the study are included in InterMune's expense guidance of February 7, 2008.

Regarding the progress of CAPACITY, the company noted that patient retention and overall study conduct remain excellent, with a low rate of patient dropouts to date. InterMune anticipates that top-line results from CAPACITY will be available in January 2009. Data from the CAPACITY trials will remain blinded during the extension study enrollment period.

The company also provided an update on the publication plans of Shionogi concerning its Phase 3 study of pirfenidone in IPF performed in Japan. The abstract of the Tuesday, May 20 presentation by Shionogi of the results of this study at the American Thoraci
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
2. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
3. InterMune Announces Start of Phase 1b Trial of ITMN-191
4. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
5. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
6. Aida Announces New Anti-Cancer Drug Under Development
7. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
8. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
10. ViroPharma Announces Discontinuation of HCV-796 Development
11. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...  PARI Respiratory Equipment has won a 2015 American Package ... by the FDA on December 2, is the first co-packaging ... ® Nebulizer for patients with cystic fibrosis. ... into this unique product offering of nebulized drug and device. ... use, we also wanted to convey that the components suit ...
(Date:6/3/2015)... The treatment pipeline for Acute Myeloid Leukemia (AML) ... Research . Analysis from business ... Market to 2020 - forecasts the value of the ... in 2013 to $878.6 million by 2020, representing a Compound ... to treat AML are expected to be approved during the ...
(Date:6/3/2015)... Medical Systems (NYSE: VAR ), world leader in radiotherapy ... the Middle East with the creation ... . Varian Medical Systems Arabia, the result of a ... today at a ceremony attended by local dignitaries and Varian,s ... represents the next step in our commitment both to cancer ...
Breaking Medicine Technology:Kitabis Pak Wins American Package Design Award 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 3Varian Establishes Local Entity in Saudi Arabia to Support Expansion in Middle East 2
... China, March 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore ... the largest retail drugstore chain in China based on the ... results for the fourth quarter and fiscal year ended December ... the quarter ended December 31, 2010: Same store ...
... today announced the appointment of Robert E. Hoffman as ... from Arena Pharmaceuticals Inc., where he held senior financial ... was vice president of finance and chief financial officer. ... of Arena,s initial public offering in 2000 and other ...
Cached Medicine Technology:China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 2China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 3China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 4China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 5China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 6China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 7China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 8China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 9China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 10China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 11China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2010 Financial Results 12Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer 2
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 ... partnership to expand online and mobile access to ... Review and Maintenance of Certification (MOC) activities. ... market VeoMed’s innovative courses to Decker’s extensive lists ... interested in purchasing access to VeoMed’s premier online ...
(Date:6/3/2015)... June 03, 2015 Peter Piot, MD, ... at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award ... level of excellence, and commitment to service on a ... President’s Award for Outstanding Contribution to Global Health that ... to advancing global health. , “DIA is ...
(Date:6/3/2015)... The panel of independent experts has spent weeks ... for the awards presented tonight at TU-Automotive Detroit 2015. ... the best-of-the-best can now be revealed as: , Car ... swept rivals aside by taking the coveted Car Maker ... our panel of expert judges., Stand out comments included: ...
(Date:6/3/2015)... 2015 Sitting at a computer for ... the back, neck, shoulders and/or wrists. This can lead ... addition, recent research links sitting for long periods as ... Fortunately, three inventors from Oakville, Ontario, are offering an ... , They have developed a prototype for a patent-pending ...
(Date:6/3/2015)... Acne is the same wherever it appears. But acne ... and hard to prevent. As with acne on the face, ... in the years when the sebaceous glands are most active. ... director and lead medical aesthetician of Simply Posh Aesthetic ... are caused by oil and dead skin clogging the pores ...
Breaking Medicine News(10 mins):Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3
... stinging pain centered on your forearms, that numbness you experience ... tunnel syndrome (CTS)at all. ,Yes, the CTS, more ... those who work for long hours with their hands could ... say. ,CTS happens when a nerve passing through ...
... A recent study indicates the negative impact of soft drinks ... Connecticut says that consumption// of sugary soft drinks lead to ... ,Brownell and his team after having researched 88 ... of these soft drinks. The research team analyzed 91,000 women ...
... lack the capacity to handle extensively drug-resistant tuberculosis, if ... is said to be resistant to two most potent ... according to some Kenyan medical experts. ... compared with $18,000 to treat multi-drug resistant TB, according ...
... to assess whether meat and dairy products from cloned animals// ... Authority (EFSA) was asked by the European Commission to look ... present, there is no specific regulation on food products from ... year, the US Food and Drug Administration (FDA) concluded that ...
... South Carolina, which will enable the early release of inmates from ... then the prisoners could bring down their stay in the jail ... Anderson who is recommending this legislation opines that the passing of ... in need of organ donors. According to ABC report there are ...
... hailed the progress of governments of Western Pacific countries in ... effort to effectively control the disease. ,The region ... least 70 percent of TB cases and curing at least ... for the health body's TB programme. ,He was ...
Cached Medicine News:Health News:Computer Programmers, need not fear Carpal Tunnel Syndrome 2Health News:EU to Look at Cloned Meat Safety 2Health News:WHO Calls for Greater Efforts to Fight TB 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: